Metagenomic next-generation sequencing for pathogen detection and management in ICU patients with sepsis

Background Rapid and accurate pathogen identification is essential for precision antimicrobial therapy in sepsis, but conventional microbiological testing (CMT) is often limited by low sensitivity, long turnaround time, and difficulty in detecting fastidious or atypical pathogens. This study aimed to evaluate the diagnostic and clinical utility of metagenomic next-generation sequencing (mNGS) in intensive care unit (ICU) patients with sepsis. Methods This retrospective cohort study enrolled 162 adult patients with sepsis admitted to the ICU of the First Affiliated Hospital of Fujian Medical University between January 2022 and September 2024. Matched clinical specimens from the same infection site were tested using both mNGS and CMT. The diagnostic performance of mNGS, pathogen spectrum, differences according to immune status, clinical adoption of mNGS results, antimicrobial adjustment, and patient outcomes were analyzed. Results Among the 162 patients, bronchoalveolar lavage fluid (BALF) was the predominant specimen (107/162, 66.05%), followed by blood (31/162, 19.14%), the cohort therefore primarily represents severe pulmonary infection rather than sepsis arising from diverse anatomical sources, and the findings should be interpreted in this context. mNGS yielded a significantly higher detection rate than CMT (81.37% vs. 56.17%, P<0.001) and identified 47 pathogenic species versus 25 by culture, including fastidious, atypical and unculturable pathogens (e.g., Mycobacterium tuberculosis, Pneumocystis jirovecii, Legionella, Rickettsia, and respiratory viruses). Against the composite clinical diagnosis, mNGS showed high sensitivity (92.55%, 95% CI 85.42-96.35%) but low specificity (35.29%, 95% CI 25.00-47.16%). mNGS results were adopted in 131 (80.9%) patients, informing targeted therapy in 80 (49.4%), de-escalation in 8 (4.9%), and confirmation of ongoing empirical therapy in 43 (26.5%). In the primary analysis, mNGS adoption was associated with lower 28-day mortality (adjusted HR 0.53, 95% CI 0.30–0.92, P = 0.025); the association was directionally consistent but not statistically significant after excluding five self-discharged patients (adjusted HR 0.65, 95% CI 0.34–1.23, P = 0.183). Conclusions mNGS substantially improves pathogen detection and may inform antimicrobial management in this predominantly respiratory ICU sepsis population; given the retrospective design and the predominance of BALF specimens, this should be regarded as hypothesis-generating rather than evidence of a definitive stewardship benefit.mNGS adoption was associated with lower short-term mortality in the primary analysis, but this exploratory finding was attenuated in a sensitivity analysis and warrants confirmation in prospective or matched studies.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular and Infection Microbiology
Published
2026-11-19
DOI
https://doi.org/10.3389/fcimb.2026.1907014
Primary Topic
Bacterial Identification and Susceptibility Testing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metagenomic next-generation sequencing for pathogen detection and management in ICU patients with sepsis

Qiong Jiang, Xiao Lin, Weihong Hong
Frontiers in Cellular and Infection Microbiology
Bacterial Identification and Susceptibility Testing
article

Metagenomic next-generation sequencing for pathogen detection and management in ICU patients with sepsis

Qiong Jiang, Xiao Lin, Weihong Hong
article en

Abstract

Background Rapid and accurate pathogen identification is essential for precision antimicrobial therapy in sepsis, but conventional microbiological testing (CMT) is often limited by low sensitivity, long turnaround time, and difficulty in detecting fastidious or atypical pathogens. This study aimed to evaluate the diagnostic and clinical utility of metagenomic next-generation sequencing (mNGS) in intensive care unit (ICU) patients with sepsis. Methods This retrospective cohort study enrolled 162 adult patients with sepsis admitted to the ICU of the First Affiliated Hospital of Fujian Medical University between January 2022 and September 2024. Matched clinical specimens from the same infection site were tested using both mNGS and CMT. The diagnostic performance of mNGS, pathogen spectrum, differences according to immune status, clinical adoption of mNGS results, antimicrobial adjustment, and patient outcomes were analyzed. Results Among the 162 patients, bronchoalveolar lavage fluid (BALF) was the predominant specimen (107/162, 66.05%), followed by blood (31/162, 19.14%), the cohort therefore primarily represents severe pulmonary infection rather than sepsis arising from diverse anatomical sources, and the findings should be interpreted in this context. mNGS yielded a significantly higher detection rate than CMT (81.37% vs. 56.17%, P<0.001) and identified 47 pathogenic species versus 25 by culture, including fastidious, atypical and unculturable pathogens (e.g., Mycobacterium tuberculosis, Pneumocystis jirovecii, Legionella, Rickettsia, and respiratory viruses). Against the composite clinical diagnosis, mNGS showed high sensitivity (92.55%, 95% CI 85.42-96.35%) but low specificity (35.29%, 95% CI 25.00-47.16%). mNGS results were adopted in 131 (80.9%) patients, informing targeted therapy in 80 (49.4%), de-escalation in 8 (4.9%), and confirmation of ongoing empirical therapy in 43 (26.5%). In the primary analysis, mNGS adoption was associated with lower 28-day mortality (adjusted HR 0.53, 95% CI 0.30–0.92, P = 0.025); the association was directionally consistent but not statistically significant after excluding five self-discharged patients (adjusted HR 0.65, 95% CI 0.34–1.23, P = 0.183). Conclusions mNGS substantially improves pathogen detection and may inform antimicrobial management in this predominantly respiratory ICU sepsis population; given the retrospective design and the predominance of BALF specimens, this should be regarded as hypothesis-generating rather than evidence of a definitive stewardship benefit.mNGS adoption was associated with lower short-term mortality in the primary analysis, but this exploratory finding was attenuated in a sensitivity analysis and warrants confirmation in prospective or matched studies.

Frontiers in Cellular and Infection MicrobiologyVol. 16
Fujian Medical University (CN), First Affiliated Hospital of Fujian Medical University (CN)
Bacterial Identification and Susceptibility Testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon